Stocks · Healthcare · Medical - Diagnostics & Research
Medpace Holdings, Inc. MEDP
$620.51 +3.51% Close, Oct 5, 2026 · NASDAQ · Market cap $16.73B
High qualityLow risk
Next earnings report: Oct 21, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +9.2%).
- The stock is in an uptrend: above its 200-day average for 72 trading days, with the 50-day average above the 200-day.
- Revenue over the last four quarters was $2.78B, up 24.7% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 28%
- EPS growth (TTM, YoY)Top 36%
- FCF growth (TTM, YoY)Top 41%
- Revenue growth, 3-year CAGRTop 30%
- Revenue growth accelerationTop 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 1%
- Gross marginBottom 18%
- Operating marginTop 12%
- Cash conversion (OCF / net income)Bottom 47%
- Accruals (lower is better)Top 27%
- Net debt / EBITDA (lower is better)Top 23%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 19%
- Free-cash-flow yieldTop 20%
- EBITDA / enterprise valueTop 29%
- Sales / enterprise valueBottom 44%
- P/E vs own 5-year history (lower is better)Bottom 22%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 44%
- 6-month returnTop 36%
- 1-year return vs S&P 500Top 47%
- Distance from 52-week highTop 14%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 40%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyBottom 1%
- Upside to consensus price targetBottom 11%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 19%
- Maximum drawdown, 3 yearsTop 12%
- Beta vs S&P 500 (lower is better)Top 43%
- Net debt / EBITDA (lower is better)Top 23%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 24.2% | 24.7% | ↑ |
| EPS growth (YoY) | 21.5% | 26.9% | ↑ |
| Gross margin | 31.6% | 28.8% | ↓ |
| Operating margin | 21.4% | 21.0% | ↓ |
| FCF margin | 26.0% | 26.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 24.7% | 24.2% | ↑ | Top 28% |
| EPS growth (TTM, YoY) | 26.9% | 21.5% | ↑ | Top 36% |
| Gross margin | 28.8% | 31.6% | ↓ | Bottom 18% |
| Operating margin | 21.0% | 21.4% | ↓ | Top 12% |
| Net margin | 17.7% | 18.7% | ↓ | — |
| Free-cash-flow margin | 26.4% | 26.0% | ↑ | — |
| Return on invested capital | 77.0% | — | Top 1% | |
| Revenue growth, 3-year CAGR | 20.1% | — | Top 30% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.53×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -7.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.64×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 1.54%
- Shareholder yield
- 1.54%
- Share count change, 1 year
- -4.7%
- Share count change, 3-year CAGR
- -3.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 23, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +9.2%
- Average 2-day reaction, last 8
- -1.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $613.78
- Target vs current price
- -1.1%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 21%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 22, 2026 | +6.8% | -0.7% | +7.4% | +11.0% | — |
| Apr 22, 2026 | +9.2% | -1.3% | -20.4% | -18.4% | +4.4% |
| Feb 9, 2026 | +11.5% | -2.2% | -21.0% | -11.7% | -20.6% |
| Oct 22, 2025 | +9.3% | +0.2% | +6.4% | +8.2% | +12.0% |
| Jul 21, 2025 | +4.0% | -1.0% | +43.5% | +46.8% | +69.1% |
| Apr 21, 2025 | +19.9% | -2.5% | +0.8% | +3.2% | +6.3% |
| Feb 10, 2025 | +24.0% | +0.1% | -3.9% | -4.7% | -18.4% |
| Oct 21, 2024 | +8.3% | -1.0% | -7.3% | -12.8% | -5.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 22, 2026 | $4.25 | $3.98 | +6.8% | $707.3M |
| Apr 22, 2026 | $4.28 | $3.92 | +9.2% | $706.6M |
| Feb 9, 2026 | $4.67 | $4.19 | +11.5% | $708.5M |
| Oct 22, 2025 | $3.86 | $3.53 | +9.3% | $659.9M |
| Jul 21, 2025 | $3.10 | $2.98 | +4.0% | $603.3M |
| Apr 21, 2025 | $3.67 | $3.06 | +19.9% | $558.6M |
| Feb 10, 2025 | $3.67 | $2.96 | +24.0% | $536.6M |
| Oct 21, 2024 | $3.01 | $2.78 | +8.3% | $533.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 36.4× | 30.7× | 76th | Top 19% |
| P/E (forward) | 35.3× | — | — | — |
| EV / EBITDA | 27.2× | — | — | Top 29% |
| EV / Sales | 5.88× | — | — | Bottom 44% |
| Free-cash-flow yield | 4.38% | — | — | Top 20% |
| Earnings yield | 2.75% | — | — | Top 19% |
P/E over the past five years
Range 21.6× – 44.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +15.7%
- Earnings per share growth (TTM)
- +26.9%
- Change in P/E multiple
- -0.1%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 72
- 50-day average slope (20 days)
- +4.6%
- 200-day average slope (20 days)
- +0.6%
- Distance from 50-day average
- +3.3%
- Distance from 200-day average
- +18.4%
- RSI (14)
- 56.1
- Relative volume
- 1.20×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 37.9%
- Volatility vs own 5-year history
- 35th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.99
- Correlation with S&P 500
- 0.30
- Current drawdown from 1-year high
- -1.5%
- Maximum drawdown, 3 years
- -39.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 27, 2021 | Apr 27, 2022 | -42.9% | 84 days | 180 days (Jan 13, 2023) |
| Jul 16, 2024 | Apr 8, 2025 | -39.4% | 183 days | 71 days (Jul 22, 2025) |
| Jan 21, 2026 | Apr 23, 2026 | -36.6% | 64 days | 83 days (Aug 21, 2026) |
| Jan 23, 2023 | Mar 13, 2023 | -27.2% | 34 days | 76 days (Jun 30, 2023) |
| Sep 13, 2023 | Oct 23, 2023 | -19.2% | 28 days | 16 days (Nov 14, 2023) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $16.73B
- P/E (TTM)
- 36.4
- EPS, diluted (TTM)
- $17.07
- Revenue (TTM)
- $2.78B
- 52-week range
- $373.00 – $677.90
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.14B | $1.46B | $1.89B | $2.11B | $2.53B |
| Gross profit | $328.2M | $432.4M | $524.5M | $656.3M | $760.6M |
| Operating income | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M |
| Net income | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M |
| EPS (diluted) | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $533.3M | $536.6M | $558.6M | $603.3M | $659.9M | $708.5M | $706.6M | $707.3M |
| Net income | $96.4M | $117.0M | $114.6M | $90.3M | $111.1M | $135.1M | $123.9M | $121.4M |
| EPS (diluted) | $3.01 | $3.67 | $3.67 | $3.10 | $3.87 | $4.67 | $4.28 | $4.25 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $263.3M | $388.1M | $433.4M | $608.8M | $713.2M |
| Capital expenditure | -$28.3M | -$36.9M | -$36.6M | -$36.5M | -$31.4M |
| Free cash flow | $235.1M | $351.2M | $396.7M | $572.3M | $681.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$62.1M | -$847.8M | -$144.0M | -$169.9M | -$860.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $502.7M
- Total assets
- $2.06B
- Total liabilities
- $1.62B
- Total debt
- $120.1M
- Net debt
- -$382.6M
- Shareholders’ equity
- $433.9M
As of Jun 30, 2026 (filed Jul 23, 2026).
Short interest
- Shares sold short
- 1,685,597
- Days to cover
- 8.82
- Change vs previous report
- +0.9%
FINRA short interest, settlement date Sep 15, 2026.